Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
CAR T-cellen gericht op Aspergillus fumigatus effectief in preklinische modellen
dec 2022 | Schimmelinfecties